Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Guri Solum"'
Autor:
Asia-Sophia Wolf, Kristin H. Bjørlykke, Hilde S. Ørbo, Sabin Bhandari, Guri Solum, Ingrid Fadum Kjønstad, Ingrid Jyssum, Unni C. Nygaard, Anja Bråthen Kristoffersen, Ingrid E. Christensen, Sarah E. Josefsson, Katrine Persgård Lund, Adity Chopra, Julie Røkke Osen, Viktoriia Chaban, Anne T. Tveter, Joseph Sexton, Tore K. Kvien, Jørgen Jahnsen, Espen A. Haavardsholm, Gunnveig Grødeland, John Torgils Vaage, Sella A. Provan, Hassen Kared, Fridtjof Lund-Johansen, Ludvig A. Munthe, Silje Watterdal Syversen, Guro Løvik Goll, Kristin Kaasen Jørgensen, Siri Mjaaland
Publikováno v:
EBioMedicine, Vol 108, Iss , Pp 105317- (2024)
Summary: Background: Understanding cellular responses to SARS-CoV-2 immunisations is important for informing vaccine recommendations in patients with inflammatory bowel disease (IBD) and other vulnerable patients on immunosuppressive therapies. This
Externí odkaz:
https://doaj.org/article/89d0f1ccaaca475d9081914fbee7e664
Autor:
Asia-Sophia Wolf, Anthony Ravussin, Marton König, Mathias H. Øverås, Guri Solum, Ingrid Fadum Kjønstad, Adity Chopra, Trygve Holmøy, Hanne F. Harbo, Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Einar August Høgestøl, Jon Torgils Vaage, Elisabeth G. Celius, Fridtjof Lund-Johansen, Ludvig A. Munthe, Gro Owren Nygaard, Siri Mjaaland
Publikováno v:
JCI Insight, Vol 8, Iss 12 (2023)
Immune responses in people with multiple sclerosis (pwMS) receiving disease-modifying therapies (DMTs) have been of significant interest throughout the COVID-19 pandemic. Lymphocyte-targeting immunotherapies, including anti-CD20 treatments and sphing
Externí odkaz:
https://doaj.org/article/5ba69269a3e644d2844eed3988e93d9c
Autor:
Hassen Kared, Asia-Sophia Wolf, Amin Alirezaylavasani, Anthony Ravussin, Guri Solum, Trung The Tran, Fridtjof Lund-Johansen, John Torgils Vaage, Lise Sofie Nissen-Meyer, Unni C. Nygaard, Olav Hungnes, Anna H. Robertson, Lisbeth Meyer Næss, Lill Trogstad, Per Magnus, Ludvig A. Munthe, Siri Mjaaland
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-12 (2022)
The SARS-CoV-2 Omicron variant possess many mutations within the receptor binding domain of the Spike protein, which confer increased transmissibility and higher antibody escape. Here, the authors carry out analysis of the serological and cellular im
Externí odkaz:
https://doaj.org/article/6657f5ba78eb43aca1470a3856bbac59
Autor:
Anthony Ravussin, Anna Hayman Robertson, Asia-Sophia Wolf, Kristine Blix, Ingrid Fadum Kjønstad, Guri Solum, Berit Feiring, Bjørn Heine Strand, Fridtjof Lund-Johansen, Ludvig A Munthe, Per Magnus, Lill Trogstad, Siri Mjaaland
Publikováno v:
The Lancet Healthy Longevity. 4:e188-e199
Autor:
Asia-Sophia Wolf, Anthony Ravussin, Marton König, Mathias H. Øverås, Guri Solum, Ingrid Fadum Kjønstad, Adity Chopra, Trygve Holmøy, Hanne F. Harbo, Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Einar August Høgestøl, Jon Torgils Vaage, Elisabeth G. Celius, Fridtjof Lund-Johansen, Ludvig A. Munthe, Gro Owren Nygaard, Siri Mjaaland
Immune responses in people with multiple sclerosis (pwMS) on disease-modifying therapies (DMTs) have been of significant interest throughout the COVID-19 pandemic. Lymphocyte-targeting immunotherapies including anti-CD20 treatments and sphingosine-1-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed4724bf248371230df8fe83cadcbe49
https://doi.org/10.1101/2022.08.25.22279202
https://doi.org/10.1101/2022.08.25.22279202
Autor:
Hassen Kared, Asia-Sophia Wolf, Amin Alirezaylavasani, Anthony Ravussin, Guri Solum, Trung The Tran, Fridtjof Lund-Johansen, John Torgils Vaage, Lise Sofie Nissen-Meyer, Unni C. Nygaard, Olav Hungnes, Anna H Robertson, Lisbeth Meyer Næss, Lill Trogstad, Per Magnus, Ludvig A Munthe, Siri Mjaaland
The new SARS-CoV-2 variant of concern (VOC) Omicron has more than 30 mutations in the receptor binding domain (RBD) of the Spike protein enabling viral escape from antibodies in vaccinated individuals and increased transmissibility1-6. It is unclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fcd372446cf25e7ed01ccce0bff47d3
https://doi.org/10.1101/2022.01.13.22269213
https://doi.org/10.1101/2022.01.13.22269213
Autor:
Svein Dueland, Karol Axcrona, Ulrika Axcrona, Lisbeth Skoge, Rolf Inge Skotheim, Stein Sæbøe-Larssen, Dolores J. Schendel, Dag Josefsen, Gunnar Kvalheim, Steinar Aamdal, Iris Bigalke, Guri Solum, Anne Merete Aaland Tryggestad, Tor Åge Myklebust, Bjørn Brennhovd, Else Marit Inderberg, Wolfgang Lilleby, Turid Kirsti Hønnåshagen, Richard W Olaussen
Publikováno v:
The ProstateREFERENCES. 82(2)
Background Patients with high-risk prostate cancer (PC) can experience biochemical relapse (BCR), despite surgery, and develop noncurative disease. The present study aimed to reduce the risk of BCR with a personalized dendritic cell (DC) vaccine, giv
Autor:
Anne Merete Aaland Tryggestad, Iris Bigalke, Wolfgang Lilleby, Karol Axcrona, Turid Kirsti Hønnåshagen, Lisbeth Johanne Skoge, Stein Sæbøe-Larssen, Guri Solum, Richard Willfred Olaussen, Dag Josefsen, Dolores Schendel, Gunnar Kvalheim
Publikováno v:
Journal of Cancer Science and Clinical Therapeutics.
Autor:
Shalini V. Rao, Kristin G. Nørsett, Barbara Niederdorfer, Guri Solum, Liv Thommesen, Geir Bjørkøy
Publikováno v:
BMC Cancer
Background: The peptide hormone gastrin exerts a growth-promoting effect in both normal and malignant gastrointestinal tissue. Gastrin mediates its effect via the cholecystokinin 2 receptor (CCKBR/CCK2R). Although a substantial part of the gastric ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff8b7f95e6016fdd425d49c678610572
http://hdl.handle.net/11250/2428508
http://hdl.handle.net/11250/2428508
Autor:
Gunnar Kvalheim, Yngvar Fløisand, Guri Solum, Stein Sæbøe-Larssen, Judith Eckl, Dolores J. Schendel, Kirsti Hønnåshagen, Iris Bigalke, Lisbeth Skoge, Christiane Geiger, Dag Josefsen
Publikováno v:
Blood. 132:2718-2718
High rates of early disease relapse are observed in patients with acute myeloid leukemia (AML). Due to poor health status, many patients cannot tolerate intensive chemotherapy and/or stem cell transplantation, resulting in a high unmet medical need f